Tracking neurodegenerative diseases in biofluids: Combining pathology and pathophysiology markers is the way
{{output}}
Biofluid biomarkers to track neurodegenerative diseases in vitam are urgently needed. Recent studies show that large-scale proteomic analyses based on the proximity extension assay may reveal novel biomarkers reflecting disease pathophysiology. Such biomarkers... ...